肝X受体在卵巢癌组织中的表达及T0901317在卵巢癌细胞系SKOV3中的作用
Expression of LXRα in ovarian carcinoma and effects of T0901317 on SKOV3 cell line

DOI: 10.6040/j.issn.1671-7554.0.2016.1548

Keywords: 增殖,卵巢肿瘤,T0901317激动剂,肝X受体,凋亡,
Ovarian cancer,Proliferation,Liver X receptors,Apoptosis,T0901317 agonist

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Zhang L, Reue K, Fong LG, et al. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis[J]. Arterioscler Thromb Vasc Biol, 2012, 32(11):2541-2546.
[2]	Raccosta L, Fontana R, Corna G, et al. Cholesterol metabolites and tumor microenvironment:the road towards clinical translation[J].Cancer Immunol Immunother,2016, 65(1):111-117.
[3]	Grover VK, Valadez JG, Bowman AB, et al. Lipid modifications of sonic hedgehog ligand dictatecellular reception and signal response[J]. PLoS One, 2011, 6(7):e21353. doi:10.1371/journal.pone.0021353.
[4]	Nelson ER, Chang CY, McDonnell DP. Cholesterol and breast cancer pathophysiology[J]. Trends Endocrinol Metab, 2014, 25(12):649-655.
[5]	Vedin LL, Lewandowski SA, Parini P, et al. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells[J]. Carcinogenesis, 2009, 30(4):575-579.
[6]	Chuu CP, Lin HP. Antiprolerative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines[J]. Anticancer Res, 2010, 30(9):3643-3648.
[7]	Kurman RJ, Shih IM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory[J]. Am J Surg Pathol, 2010, 34(3):433-443.
[8]	Rough JJ, Monroy MA, Yerrum S, et al. Antiproliferative effect of LXR agonist T0901317 in ovarian carcinoma cells[J]. J Ovarian Res, 2010, 3:13. doi:10.1186/1757-2215-3-13.
[9]	Roshan-Moniri M, Hsing M, Butler MS, et al. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers[J]. Cancer Treat Rev, 2014, 40(10):1137-1152.
[10]	Savic D, Ramaker RC, Roberts BS, et al. Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation[J]. Genome Med, 2016, 8(1):74. doi:10.1186/s13073-016-0328-6.
[11]	涂剑, 刘晓旺, 丁维珂, 等. T0901317促进人乳腺癌细胞凋亡的研究[J]. 中国临床药理学与治疗学, 2015, 50(12):1340-1347. TU Jian, LIU Xiaowang, DING Weike, et al. T0901 317 induces the apoptosis of MCF-7 and MDA-MB-231 human breast cancer cells[J]. Chinese Journal of Clinical Pharmacology and Therapeytics, 2015, 50(12):1340-1347.
[12]	Jayson GC, Kohn EC, Kitchener HC, et al. Ovarian cancer[J]. Lancet, 2014, 384(9951):1376-1388.
[13]	Bast RC Jr, Hennessy B, Mills GB, et al. The biology of ovarian cancer:new opportunities for translation[J]. Nat Rev Cancer, 2009, 9(6):415-428.
[14]	Vaughan S, Coward JI, Bast RC Jr, et al. Rethinking ovarian cancer:recommendations for improving outcomes[J]. Nat Rev Cancer, 2011, 11(10):719-725.
[15]	刘晓旺, 陆凯强, 熊婷, 等. 肝X受体—癌症治疗新靶点[J]. 临床与病理杂志, 2016, 36(5):690-694. LIU Xiaowang, LU Kaiqiang, XIONG Ting, et al. Liver X receptors—a new targets for cancer treatment[J]. Journal of Clinical and Pathological Research, 2016, 36(5):690-694.
[16]	Wang Q, Sun L, Yang X, et al. Activation of liver X receptor inhibits the development of pulmonary carcinomas induced by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c mice[J]. Sci Rep, 2016, 6:27295. doi:10.1038/srep27295.
[17]	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1):5-29.
[18]	Grover VK, Valadez JG, Bowman AB, et al. Lipid modifications of sonic hedgehog ligand dictate cellular reception and signal response[J]. PLoS One, 2011, 6(7):e21353. doi:10.1371/journal.pone.0021353.
[19]	Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5):71-96.
[20]	Nguyen-Vu T, Vedin LL, Liu K, et al. Liver x receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism[J]. Breast Cancer Res, 2013, 15(3):R51. doi:10.1186/bcr3443.
[21]	Krycer JR, Brown AJ. Does changing androgen receptor status during prostate cancer development impact upon cholesterol homeostasis?[J]. PLoS One, 2013, 8(1):e54007. doi:10.1371/journal.
[22]	Scoles DR, Xu X, Wang H, et al. Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein[J]. Gynecol Oncol, 2010, 116(1):109-116.
[23]	Zhang L, Reue K, Fong LG, et al. Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis. Arterioscler[J]. Arterioscler Thromb Vasc Biol, 2012, 32(11):2541-2546.
[24]	De Boussac H, Alioui A, Viennois E, et al. Oxysterol receptors and their therapeutic applications in cancer conditions[J]. Expert Opin Ther Targets, 2013, 17(9):1029-1038.
[25]	Nelson ER, Wardell SE, Jasper JS, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology[J]. In Science, 2013, 342(6162):1094-1098.

Full-Text